SavedAdd your journal

Journals / MN Kardiyoloji / 2014 / Cilt: 21 - Sayı: 4

Treatment method of cerebral intraventriculer hemorrhage due to warfarin on patient with mechanic valve replacement

Mekanik kapak replasmanı olan hastada varfarin kullanımına bağlı gelişen serebral intraventriküler kanamanın tedavi yönetimi

MUHAMMET GÜRDOĞAN
Hasan ARI
Mehmet ERTÜRK
Sabahittin ÖZAKBAŞ
Pages
231–234
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we presented suggestions about treatment of cerebral intraventriculer hemorrhage due to warfarin on patient with mechanic valve replacement.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It is difficult to treat patients with intracranial hemorrhage who are using warfarin.
📊
Key Findings & Data:A 65 years old man, who experienced mechanic valve replacement and coronary by pass operations six years ago and applied with severe headache, is represented in this case report.
💡
Conclusion & Impact:In this article, we presented suggestions about treatment of cerebral intraventriculer hemorrhage due to warfarin on patient with mechanic valve replacement.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

It is difficult to treat patients with intracranial hemorrhage who are using warfarin. It's vital to terminate the anticoagulant effect immediately but this attempt reveals the risk of tromboembolic complications. Optimum restart time and prefered international normalized ratio (INR) level of anticoagulant treatment is controversial. A 65 years old man, who experienced mechanic valve replacement and coronary by pass operations six years ago and applied with severe headache, is represented in this case report. Somnolence and weakness on left arm was detected by physical examination. Hiperdens appearance concordant with hemorrhage on right lateral ventricle was observed by computerized cerebral tomography (CCT). In this article, we presented suggestions about treatment of cerebral intraventriculer hemorrhage due to warfarin on patient with mechanic valve replacement.

Özet

Varfarin kullanan ve intrakranyal kanama gelişen hastaların tedavisi zordur. Antikoagülan etkisinin hızla sonlandırılması kanamanın durdurulması için hayati önem taşırken, tromboembolik komplikasyonların oluşma riskini beraberinde getirmektedir. Antikoagülan tedaviye yeniden başlanması için ideal zamanın ne olması gerektiği ve hedeflenen uluslararası normalleştirilmiş oran (INR) düzeyi ile ilgili bilgiler tartışmalıdır. Bu yazıda şiddetli baş ağrısı nedeniyle kliniğimize başvuran 65 yaşında bir olgu sunuldu. Altı yıl önce metalik aort kapak replasmanı ve koroner baypas operasyonu olan olgunun fizik muayenesinde uykuya meyilli ve sol kolda güç kaybı olduğu görüldü. Yapılan bilgisayarlı beyin tomografisinde (BBT) sağ lateral ventrikülde hemoraji ile uyumlu hiperdens görünüm izlendi. Bu makalede, mekanik kalp kapağı replasmanı olan hastada varfarin kullanımına bağlı gelişen serebral intraventriküler kanamanın tedavi yönetimi hakkında öneriler sunduk.

🔖

Cite This Article

GÜRDOĞAN, M., ARI, H., ERTÜRK, M., ÖZAKBAŞ, S. (2014). Treatment method of cerebral intraventriculer hemorrhage due to warfarin on patient with mechanic valve replacement. MN Kardiyoloji, Cilt: 21 - Sayı: 4, 231–234. https://ajindex.com/articles/297890

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Pala- reti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:160-98
  2. Panduranga P1, Al-Mukhaini M, Al-Muslahi M, Haque MA, Shehab A. Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding. World J Cardiol 2012;26;4(3):54-9
  3. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focu- sed update incorporated into the ACC/AHA 2006 guide- lines for the management of patients with valvular heart disease: a report of the American College of Cardio- logy/American Heart Association Task Force on Practice Guidelines (Writing Com mit tee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovas- cular Anesthesiologists, Society for Cardiovascular Angi- ography and Interventions, and Society of Thoracic Sur- geons. Circulation 2008;118:523-661
  4. Butler AC, Tait RC. Restarting anticoagulation in prosthe- tic heart valve patients after intracranial haemorrhage: a 2-year follow-up. Br J Haematol 1998;103:1064-6
  5. Crawley F, Bevan D, Wren D. Management of intracranial bleeding associated with anticoagulation: balancing the risk of further bleeding against thromboembolism from prosthetic heart valves. J Neurol Neurosurg Psychiatry 2000 Sep;69(3):396-8
  6. Pernod G, Godiér A, Gozalo C, Tremey B, Sié P. French clinical practice guidelines on the management of pa- tients on vitamin K antagonists in at-risk situations (over- dose, risk of bleeding, and active bleeding). Thromb Res 2010;126(3):167-74.